Standard BioTools Inc
NASDAQ:LAB
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.42
2.92
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Standard BioTools Inc
Relative Value
The Relative Value of one
LAB
stock under the Base Case scenario is
1.09
USD.
Compared to the current market price of 1.71 USD,
Standard BioTools Inc
is
Overvalued by 36%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
LAB Competitors Multiples
Standard BioTools Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Standard BioTools Inc
NASDAQ:LAB
|
632.6m USD | 4.6 | -3.8 | -2.5 | -2.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.3T USD | 464.1 | 4 966.6 | 1 567.3 | 3 339.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
196.2B USD | 4.6 | 32 | 20.8 | 29.8 | |
| US |
|
Danaher Corp
NYSE:DHR
|
170.9B USD | 8 | 43.9 | 27.5 | 41.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
67.6T KRW | 15.5 | 64.2 | 34.8 | 50 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.3B CHF | 5.7 | 66.8 | 45.2 | 45.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
38.6B USD | 5.9 | 27.3 | 21.4 | 24.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
36.5B USD | 2.4 | 26 | 14.3 | 21.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7.1 | 33.6 | 24.1 | 26.9 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
23.2B USD | 8 | 46.3 | 31.1 | 39 | |
| US |
|
Waters Corp
NYSE:WAT
|
23B USD | 7.9 | 37 | 23.6 | 28.9 |
You don't have any saved screeners yet
